168 related articles for article (PubMed ID: 31471636)
1. Sebaceous carcinoma: controversies and their evidence for clinical practice.
Kibbi N; Worley B; Owen JL; Kelm RC; Bichakjian CK; Chandra S; Demirci H; Kim J; Nehal KS; Thomas JR; Poon E; Alam M
Arch Dermatol Res; 2020 Jan; 312(1):25-31. PubMed ID: 31471636
[TBL] [Abstract][Full Text] [Related]
2. Sebaceous carcinoma epidemiology, associated malignancies and Lynch/Muir-Torre syndrome screening in England from 2008 to 2018.
Cook S; Pethick J; Kibbi N; Hollestein L; Lavelle K; de Vere Hunt I; Turnbull C; Rous B; Husain A; Burn J; Lüchtenborg M; Santaniello F; McRonald F; Hardy S; Linos E; Venables Z; Rajan N
J Am Acad Dermatol; 2023 Dec; 89(6):1129-1135. PubMed ID: 37031776
[TBL] [Abstract][Full Text] [Related]
3. Comparison of clinicopathologic features, survival, and demographics in sebaceous carcinoma patients with and without Muir-Torre syndrome.
Maloney NJ; Zacher NC; Hirotsu KE; Rajan N; Aasi SZ; Kibbi N
J Am Acad Dermatol; 2023 Aug; 89(2):269-273. PubMed ID: 37003478
[TBL] [Abstract][Full Text] [Related]
4. Cystic sebaceous carcinoma: is it a constant pathognomic marker for Muir-Torre syndrome?
Al-Shobaili HA; AlGhamdi KM; Al-Ghamdi WA
J Drugs Dermatol; 2007 May; 6(5):540-3. PubMed ID: 17679191
[TBL] [Abstract][Full Text] [Related]
5. S1-Guideline Sebaceous Carcinoma.
Utikal J; Nagel P; Müller V; Becker JC; Dippel E; Frisman A; Gschnell M; Griewank K; Hadaschik E; Helbig D; Hillen U; Leiter U; Pföhler C; Krönig L; Ziemer M; Ugurel S
J Dtsch Dermatol Ges; 2024 May; 22(5):730-747. PubMed ID: 38679790
[TBL] [Abstract][Full Text] [Related]
6. Muir-Torre Syndrome Associated Periocular Sebaceous Neoplasms: Screening Patterns in the Literature and in Clinical Practice.
Eiger-Moscovich M; Eagle RC; Shields CL; Racher H; Lally SE; Silkiss RZ; Shields JA; Milman T
Ocul Oncol Pathol; 2020 Aug; 6(4):226-237. PubMed ID: 33005611
[TBL] [Abstract][Full Text] [Related]
7. Extraocular sebaceous carcinoma in a patient with Muir-Torre syndrome.
Harrington CR; Egbert BM; Swetter SM
Dermatol Surg; 2004 May; 30(5):817-9. PubMed ID: 15099333
[TBL] [Abstract][Full Text] [Related]
8. Management Considerations in Extraocular Sebaceous Carcinoma.
Chang AY; Miller CJ; Elenitsas R; Newman JG; Sobanko JF
Dermatol Surg; 2016 Jan; 42 Suppl 1():S57-65. PubMed ID: 26730975
[TBL] [Abstract][Full Text] [Related]
9. Extraocular sebaceous carcinoma: a report of 2 cases.
Cieza-Díaz DE; Cano-Martínez N; Barchino-Ortiz L; Longo-Imedio I
Actas Dermosifiliogr; 2012 Dec; 103(10):919-22. PubMed ID: 23149052
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor (EGFR) expression in periocular and extraocular sebaceous carcinoma.
Ivan D; Prieto VG; Esmaeli B; Wistuba II; Tang X; Lazar AJ
J Cutan Pathol; 2010 Feb; 37(2):231-6. PubMed ID: 19614729
[TBL] [Abstract][Full Text] [Related]
11. Aggressive sebaceous carcinoma of the head.
Scuderi S; Giaccone M; D'Errico E; Maorenzic MA; Fontanellaa M; Castellano I; Zanon C; Gaetini AM
Chir Ital; 2009; 61(3):401-4. PubMed ID: 19694247
[TBL] [Abstract][Full Text] [Related]
12. Sebaceous gland tumors of the eyelids and conjunctiva in the Muir-Torre syndrome: a clinicopathologic study of five cases and literature review.
Rishi K; Font RL
Ophthalmic Plast Reconstr Surg; 2004 Jan; 20(1):31-6. PubMed ID: 14752307
[TBL] [Abstract][Full Text] [Related]
13. Sebaceous carcinoma: the great masquerader: emgerging concepts in diagnosis and treatment.
Buitrago W; Joseph AK
Dermatol Ther; 2008; 21(6):459-66. PubMed ID: 19076624
[TBL] [Abstract][Full Text] [Related]
14. Sebaceous Neoplasms.
Flux K
Surg Pathol Clin; 2017 Jun; 10(2):367-382. PubMed ID: 28477886
[TBL] [Abstract][Full Text] [Related]
15. Muir-Torre syndrome.
Lachiewicz AM; Wilkinson TM; Groben P; Ollila DW; Thomas NE
Am J Clin Dermatol; 2007; 8(5):315-9. PubMed ID: 17902735
[TBL] [Abstract][Full Text] [Related]
16. Sebaceous Carcinoma: A Review of the Scientific Literature.
Knackstedt T; Samie FH
Curr Treat Options Oncol; 2017 Aug; 18(8):47. PubMed ID: 28681210
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes in Sebaceous Carcinoma: A Retrospective Two-Center Cohort Study.
Kibbi N; Petric UB; El-Banna G; Beaulieu DM; Rajan N; Srivastava D; Aasi SZ
Dermatol Surg; 2023 Dec; 49(12):1122-1127. PubMed ID: 37962979
[TBL] [Abstract][Full Text] [Related]
18. Muir-Torre syndrome (MTS): An update and approach to diagnosis and management.
John AM; Schwartz RA
J Am Acad Dermatol; 2016 Mar; 74(3):558-66. PubMed ID: 26892655
[TBL] [Abstract][Full Text] [Related]
19. Muir-Torre syndrome: sebaceous carcinoma concurrent with colon cancer in a kidney transplant recipient; a case report.
Tomonari M; Shimada M; Nakada Y; Yamamoto I; Itoh M; Koike Y; Kobayashi A; Miki J; Yamada H; Kimura T; Saito S; Sugano K; Sekine S; Yamamoto H; Asahina A; Yokoo T
BMC Nephrol; 2019 Oct; 20(1):394. PubMed ID: 31664942
[TBL] [Abstract][Full Text] [Related]
20. Sebaceous carcinoma: an updated review of pathogenesis, diagnosis, and treatment options.
Dowell-Esquivel C; Lee R; DiCaprio RC; Nouri K
Arch Dermatol Res; 2023 Dec; 316(1):55. PubMed ID: 38112896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
